News New Enterprise Associates owns 75 percent of GlycoMimetics – Washington Business Journal Bicoastal venture firm New Enterprise Associates owns 75.2 percent of GlycoMimetics Inc.,…Super UserOctober 8, 2013
News MacroGenics slated to go public this week – Washington Business Journal MacroGenics Inc. is slated to go public this week. The Rockville drug-maker…Super UserOctober 8, 2013
News Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD),…Super UserOctober 7, 2013
News Darpa Courts Biotech Researchers – Government – The Chronicle of Higher Education Donald E. Ingber, a professor at Harvard University, has combined advanced electronics…Super UserOctober 7, 2013
News Glycomimetics Files Registration Statement for Proposed Initial Public Offering – GlycoMimetics GlycoMimetics, Inc. announced today that it has filed a registration statement on…Super UserOctober 7, 2013
News High Blood Sugar Linked with Cancer – TeleManagement Even people without diabetes could be at higher risk of dying from…Super UserOctober 7, 2013
News BioMarker Strategies Appoints Jerry Parrott President and CEO – HispanicBusiness.com BioMarker Strategies announced the appointment of Jerry Parrott as President, Chief Executive…Super UserOctober 7, 2013
News Fyodor Awarded SBIR Phase 2 Grant Fyodor, a Baltimore-based biotechnology company, announced today that the US National Science…Super UserOctober 7, 2013
News Epigenomics AG: Epigenomics signs joint commercialization agreement for Epi proColon® in North America with Polymedco Berlin, Germany, and U.S.A. - Epigenomics AG (Frankfurt Prime Standard: ECX, OTC:…Super UserOctober 7, 2013
News New Enterprise Associates joins $10M round for drug accelerator – Washington Business Journal Chevy Chase-based New Enterprise Associates has joined in a $10 million financing…Super UserOctober 7, 2013